Search
Search Results
##search.searchResults.foundPlural##
-
THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
3971PDF: 1113HTML: 1914Fig.1: 204Fig. 2: 101Table 1: 183Table2: 199Table 3: 180 -
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2516PDF: 1568HTML: 2334Table1: 172 -
IS THERE A ROLE FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA IN THE CHEMO-IMMUNOTHERAPY ERA?
3298PDF: 1246HTML: 2190Fi.1 Gritti.Rambaldi: 185 -
Tenofovir as Rescue Therapy Following Clinical Failure to Lamivudine in Severe Acute Hepatitis B
2061PDF: 791HTML: 1626Figure 1: 188 -
-
Sorafenib induced Hand Foot Skin Rash in FLT3 ITD mutated Acute Myeloid leukemia- A case report and review of literature
1814PDF: 872HTML: 1741Sorafenib induced Hand Foot Skin Rash in FLT3 ITD mutated AML- IMAGES: 142 -
FOLLICULAR LYMPHOMA: THE MANAGEMENT OF ELDERLY PATIENT
4303PDF: 1575HTML: 3387Tables and Images: 194 -
DNA Repair Genes and Chronic Myeloid Leukemia: XPD (751), XRCC1 (399), XRCC4-Intron 3, XRCC4 (1394) Gene Polymorphisms Polymorphisms of DNA Repair Genes in CML
1036PDF: 382HTML: 218 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
3992PDF: 1534HTML: 834 -
TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA
3226PDF: 1429HTML: 3974 -
PREVALENCE OF HEPATITIS B, HEPATITIS C AND HIV IN MULTIPLY TRANSFUSED SICKLE CELL DISEASE PATIENTS FROM OMAN HBV,HCV and HIV and Sickle Cell Disease.
1535PDF: 957HTML: 342 -
TUBERCULOSIS IN HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS.
2553PDF: 913HTML: 3575 -
Cardiac toxicity associated with HCV direct antiviral agents Heart in HCV DAAs therapy
1496PDF: 944HTML: 153 -
APLASTIC ANEMIA AND VIRAL HEPATITIS
1215PDF: 513HTML: 22992 -
VIRAL HEPATITIS A TO E IN SOUTH MEDITERRANEAN COUNTRIES
1198PDF: 631HTML: 7706 -
TREATMENT OF LOW-BLAST COUNT AML USING HYPOMETHYLATING AGENTS
4206PDF: 1704HTML: 1095 -
THE ROLE OF SLC22A4 IN ACUTE MYELOID LEUKEMIA
389PDF: 200HTML: 70 -
-
LYMPHOCYTES IN PATIENTS WITH CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1 EXPRESSION AND A PREVAILING TH2 IMMUNE RESPONSE. EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1
2544PDF: 1043HTML: 98 -
THE PROTHROMBOTIC STATE ASSOCIATED WITH SARS-COV-2 INFECTION: PATHOPHYSIOLOGICAL ASPECTS COVID and Thrombosis
1866PDF: 768HTML: 204 -
FROM LEGACY TO INNOVATION: PIDOTIMOD’S EXPANDING THERAPEUTIC HORIZON Pidotimod: Revisiting a Classic Immunomodulator
2070PDF: 838HTML: 297 -
IDENTİFİCATİON OF LEİSHMANİA TROPİCA FROM PEDİATRİC VİSCERAL LEİSHMANİASİS İN SOUTHERN MEDITERRANEAN REGION OF TURKEY. Molecular characterization of pediatric visceral leishmaniasis
920PDF: 662HTML: 211 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
4240PDF: 1448HTML: 1531Untitled: 209 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3424PDF: 2332HTML: 1411 -
A CRITICAL HISTORY OF CHRONIC MYELOID LEUKEMIA
3155PDF: 1299HTML: 4104 -
DEMOGRAPHICAL, VIRO-IMMUNOLOGICAL, CLINICAL AND THERAPEUTICAL CHARACTERISTICS OF HIV INFECTED PATIENTS IN A “EPIDEMIOLOGICALLY UNEXPLORED” REGION OF ITALY (CALABRIA REGION): THE CALABRHIV COHORT.
1553PDF: 761HTML: 1219Figure 1: 144Figure 2: 166Figure 3: 163







